612-76-0

Usage

Uses

Used in Polymer and Plastics Industry:
3,3'-Dihydroxybiphenyl is utilized as a precursor in the production of various polymers and plastics. Its chemical structure allows it to be a fundamental building block in the synthesis of these materials, contributing to their development and improvement.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 3,3'-Dihydroxybiphenyl is employed for its potential health benefits. Its antioxidant properties make it a candidate for further research and development in the context of medicinal applications.
Used in Agricultural Industry:
3,3'-Dihydroxybiphenyl also has potential applications in agriculture. Its properties may be harnessed to develop new products or enhance existing ones, contributing to advancements in this field.
Used in Antioxidant Formulations:
3,3'-Dihydroxybiphenyl is used as an antioxidant in various formulations. Its ability to inhibit oxidative processes makes it a valuable component in products designed to protect against oxidative stress and related conditions.
Used in Cancer Research:
3,3'-Dihydroxybiphenyl is used in research as a potential agent to inhibit the growth of certain types of cancer cells. Its properties are being studied to understand its mechanisms of action and to explore its potential as a therapeutic agent in oncology.

Upstream product

• 53385-78-7 1-propyl-1,2,3,6-tetrahydropyridine 
• 626-02-8 3-Iodophenol 
• 87199-18-6 3-hydroxyphenylboronic acid 
• 108-43-0 3-monochlorophenol 
• 933-78-8 2,3,5-trichlorophenol 

Downstream Products

• 108-95-2 phenol 
• 359686-80-9 3,3'-Bis[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-2,2',4,4',6,6'-hexaiodo-1,1'-biphenyl 
• 14184-98-6 3,3'-dihydroxy-2,2',4,4',6,6'-hexanitrobiphenyl 
• 209725-87-1 2-[6-Benzyloxy-2-(2-ethyl-hexylamino)-purin-9-yl]-N-{2-[3'-(2-{2-[6-benzyloxy-2-(2-ethyl-hexylamino)-purin-9-yl]-acetylamino}-ethoxy)-biphenyl-3-yloxy]-ethyl}-acetamide 
• 209725-86-0 2-[6-Benzyloxy-2-(2-methyl-butylamino)-purin-9-yl]-N-{2-[3'-(2-{2-[6-benzyloxy-2-(2-methyl-butylamino)-purin-9-yl]-acetylamino}-ethoxy)-biphenyl-3-yloxy]-ethyl}-acetamide 
• 209725-85-9 2-(2-Amino-6-benzyloxy-purin-9-yl)-N-[2-(3'-{2-[2-(2-amino-6-benzyloxy-purin-9-yl)-acetylamino]-ethoxy}-biphenyl-3-yloxy)-ethyl]-acetamide 
• 209725-88-2 2-(6-Benzyloxy-2-octadecylamino-purin-9-yl)-N-[2-(3'-{2-[2-(6-benzyloxy-2-octadecylamino-purin-9-yl)-acetylamino]-ethoxy}-biphenyl-3-yloxy)-ethyl]-acetamide 
• 6161-50-8 3,3'-dimethoxybiphenyl 

Relevant academic research and scientific papers

Active-alkali metal-promoted reductive cleavage of chlorinated phenols

We investigated the degradation of chlorinated phenols under reductive electron transfer reaction conditions. Although Li and Na metal proved useless, activated forms of these metals, either their soluble naphthalene radical anions or 1,2-diarylethane dianions, promoted the degradation of the starting materials to various extents. Additionally, efficient dehalogenation of the sodium salts of several mono-, di-, and tri-chlorophenols was obtained by their reduction with an excess of Na metal and a catalytic amount of naphthalene. Springer-Verlag 2012.

[Pd(L)Cl2]-catalyzed selective hydroxylation of arylboronic acids to phenols

The palladium complex [Pd(L)Cl2] (1) has been prepared by the reaction of Pd(COD)Cl2 (COD = 1,5-cyclooctadiene) with L [N,N′-bis(diphenylphosphanyl)-2-(diphenylphosphanyl)ethanamine]. The ligand L and complex 1 have been characterized by elemental analysis, mass spectrometry and 1H/31P NMR spectroscopy. In the presence of O2, 1 selectively catalyzes the hydroxylation of a variety of arylboronic acids to the corresponding phenol derivatives in solvents with low-dielectric constants at 298 K, although in solvents with high dielectric constants the same reaction leads to the formation of both phenol and the coupled product, i.e. biaryl. The mechanistic aspects of the selective phenol formation from arylboronic acid with 1 have been addressed.

2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics

Analgesic 1,2,3,4-tetrahydroisoquinolines of the formula (1) STR1 wherein R1 and R2 respectively are hydrogen, hydroxy or alkoxy of 1 to 4 carbon atoms, R3 and R4 respectively are hydrogen or alkyl of 1 to 4 car

Anti-arteriosclerotic agents

Novel substituted arylene compounds and methods for their preparation and use are disclosed. These new compounds are useful as anti-arteriosclerotic agents.

Process for producing bisphenols

Bisphenols, substantially free of by-products, are produced rapidly by reacting a phenol and a compound of the formula STR1 wherein R and R' are independently selected from the group consisting of hydrogen, lower alkyl or aryl; X is lower acyloxy; Y is lower alkoxy, aryloxy or the same as X; Z is the divalent radical STR2 wherein R" and R'" are selected from the same category as R and R', and n is an integer from 3 to 9; m=(n-1).